CD79A and cancer: Although, further studies are necessary to clarify the direct mechanisms of IgA antibody-mediated anti-cancer effect, we suggest that the oral-administration of rGA733-Fc increases the production of tumor antigen-targeting antibodies and may have a therapeutic potential for colon cancer patients.